EyePoint (NASDAQ: EYE) files to sell 35,000 shares via Fidelity Brokerage

Rhea-AI Filing Summary

EyePoint Pharmaceuticals notified the SEC of a proposed sale of 35,000 shares of Common Stock via Fidelity Brokerage Services LLC, with an aggregate value of $955,500.00, filed on 03/11/2026. The filing lists 34,242 shares from restricted stock vesting (08/19/2025) and 758 shares from an ESPP purchase (11/28/2025). Shares outstanding were 79,437,185 as of 03/11/2026.

Insights

Securities Attorney

Routine Rule 144 notice for an intended sale of restricted and ESPP shares.

The filing describes a proposed resale of 35,000 shares through Fidelity with an aggregate value of $955,500.00. It identifies vesting and ESPP sources: 34,242 (restricted stock vesting, 08/19/2025) and 758 (ESPP purchase, 11/28/2025).

Timing and distribution mechanics beyond the broker identity are not detailed here; any sale remains subject to Rule 144 conditions and market execution practices. Subsequent filings would show actual transactions.

Capital Markets Analyst

Administrative resale notice with limited market impact.

The notice lists shares outstanding of 79,437,185 as of 03/11/2026, giving scale to the proposed 35,000-share sale (approximately a small fraction of outstanding stock). The filing names Fidelity Brokerage Services LLC as the broker.

Actual market impact depends on execution method and timing, which are not specified in the excerpt; subsequent transaction reports would confirm whether the sale occurred.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	35000	955500.00	79437185	03/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	Restricted Stock Vesting	Issuer			34242	08/19/2025	Compensation
Common	11/28/2025	ESPP Purchase	Issuer			758	11/28/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the EYE Form 144 disclose about the proposed sale?

It discloses a proposed sale of 35,000 shares with an aggregate value of $955,500.00, filed on 03/11/2026. The notice lists sources as restricted stock vesting and an ESPP purchase.

How many shares are listed from restricted stock and ESPP in the filing?

The filing lists 34,242 shares from restricted stock vesting (dated 08/19/2025) and 758 shares from an ESPP purchase (dated 11/28/2025), as components of the proposed sale.

Who is the broker handling the proposed EYE sale?

The notice names Fidelity Brokerage Services LLC as the broker-dealer for the proposed transaction, with the filing indicating execution via that brokerage on 03/11/2026.

What is the company share count noted in the filing?

The filing shows shares outstanding of 79,437,185 as of 03/11/2026, providing context for the scale of the proposed 35,000-share sale relative to total shares outstanding.

Does the Form 144 confirm the sale was completed?

No; the Form 144 reports a proposed sale under Rule 144 but does not confirm execution. Completion and settlement details would appear in subsequent transaction reports or broker confirmations.